SAT-158 New Data on High Prevalence and Time of Occurrence of New Onset Hypothyroidism Associated with Mitotane Therapy in a Cohort of Adrenocortical Cancer

Context. Mitotane is a steroidogenesis inhibitor and an adrenocorticolytic drug used to treat adrenocortical cancer (ACC). Central hypothyroidism is recognized in mitotane-treated patients and recent data suggested that mitotane could have an inhibitory effect on TSH-secreting cells in the pituitary...

Descripción completa

Detalles Bibliográficos
Autores principales: Poirier, Jonathan, Lacroix, André, Olney, Harold J, Bourdeau, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Adrenal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207913/
http://dx.doi.org/10.1210/jendso/bvaa046.1590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207913/
http://dx.doi.org/10.1210/jendso/bvaa046.1590

Ejemplares similares